1 citations
,
July 2024 in “New Phytologist” ZmSPL10, ZmSPL14, and ZmSPL26 genes are essential for forming maize structures needed for pollen capture and kernel production.
22 citations
,
May 2002 in “Skin Research and Technology” CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.
64 citations
,
August 2019 in “Circulation” ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.
October 2024 in “Developmental Dynamics” Recent advances show zebrafish can model anemia, Alx4 affects craniofacial and hair development, and mTORC1 is crucial for retinal development.
March 2026 in “Journal of Multidisciplinary Applied Natural Science” Cosmos caudatus extract is as effective as finasteride for treating benign prostatic hyperplasia without its side effects.
37 citations
,
September 2002 in “Acta pædiatrica” A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.
October 2023 in “Lithuanian University of Health Sciences” The TG5 gene affects beef cattle weight, and the CC genotype leads to higher weights.
2 citations
,
August 2022 in “World Journal of Clinical Cases” Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.
2 citations
,
May 2020 in “Journal of the American Academy of Dermatology” Hair shaft changes may be linked to CCCA, but their role is unclear.
5 citations
,
April 2023 in “Life” CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.
7 citations
,
August 2022 in “Experimental dermatology” Blocking YAP/TAZ could be a new way to treat skin cancer.
November 2022 in “International journal of biology, pharmacy and allied sciences” The new herbal shampoo is effective, safe, and more affordable than other products.
1 citations
,
September 2008 in “International Journal of Cosmetic Science” Cassia HPTC is an effective hair conditioner, better than some traditional formulas.
February 2024 in “Future science OA” Loss of the Y chromosome and UTY gene activity increases cancer risk in men.
August 2023 in “Zenodo (CERN European Organization for Nuclear Research)” 9 citations
,
May 2014 in “Clinical Cosmetic and Investigational Dermatology” Using tazarotene with GliSODin improves facial skin more than tazarotene alone.
April 2024 in “Journal of the American Academy of Dermatology” Diagnosing and treating CCCA requires understanding multiple causes and using various diagnostic tools.
1 citations
,
March 2022 in “Frontiers in Medicine” Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.
6 citations
,
December 1997 in “Journal of The American Academy of Dermatology” CTE can distort results in hair growth trials, so exclude it carefully.
164 citations
,
December 1984 in “Proceedings of the National Academy of Sciences” TCDD reduces EGF receptor activity and causes various developmental changes in animals.
1 citations
,
April 2021 in “IOP Conference Series Earth and Environmental Science” Two rice strains showed stable high yield and Zinc content in different climates.
December 2024 in “Veterinary Dermatology” A sugar glider had a rare skin cancer that worsened despite treatment, highlighting the need for thorough checks in exotic pets.
July 2023 in “Nasza Dermatologia Online” More research is needed on CCCA in children, especially Black and Asian adolescents.
June 2020 in “bioRxiv (Cold Spring Harbor Laboratory)” Activating β-catenin increases melanocytes and decreases Schwann cells.
June 2026 in “Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)” Topical IKKα inhibitors may help prevent CCS tumours.
Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.
April 2026 in “Journal of Ethnopharmacology” 
May 2026 in “Research Square” This study explored the effectiveness of combining scalp cooling therapy with a DHL-HisZnNa-containing lotion to prevent chemotherapy-induced alopecia (CIA) in breast cancer patients. Among 23 analyzed participants, 91.3% showed improvement in hair loss 90 days post-chemotherapy, with all patients improving to Grade 1 alopecia or lower. The combination therapy was effective in preventing severe hair loss and demonstrated favorable safety, though some patients still experienced Grade 1 alopecia. The study noted that specific chemotherapy regimens, like the TC regimen, might delay hair volume recovery. Despite the small sample size and absence of a control group, the findings suggest this approach could enhance quality of life by reducing CIA and promoting hair regrowth, though further research is needed.
March 2022 in “JAAD case reports” Accurate diagnosis is crucial for effective treatment of hair loss.
2 citations
,
May 2021 in “Clinical Pharmacology in Drug Development” Clascoterone is safe for the heart, even at high doses.